According to data from the Ministry of Agriculture and Rural Affairs, a total of 6,226 cases of African Swine Fever were reported globally from January to May, infecting over 167,000 pigs. It is worth noting that in March alone, there were 1,399 cases and over 68,000 pigs were infected. Data shows that among the countries experiencing outbreaks of African Swine Fever worldwide, those in Europe and Southeast Asia are the most obvious.
African swine fever (ASF) poses a serious threat to pig farming, food security, and the global economy. It is one of the most destructive diseases of domestic pigs and wild boars worldwide, with a mortality rate of 100%. From January 2022 to February 28, 2025, more than 2 million pigs were lost globally due to African swine fever, with Asia and Europe being the hardest hit and endangering food security. Previously, due to the lack of effective vaccines or therapies, prevention and control were extremely difficult. In recent years, some vaccines have been used in fields in a few countries. WOAH encourages innovation in vaccine research and development, emphasizing the importance of high-quality, safe, and effective vaccines.
On December 24, 2024, a remarkable research achievement was published in the journal Vaccines, led by Harbin Institute of Veterinary Medicine, Chinese Academy of Agricultural Sciences. It introduced the development and preliminary effects of a bacterial like particle (BLPs) vaccine that can display ASFV antigen.
Although BLPs technology has achieved certain results in laboratory research, it still needs to go through strict clinical trials, approval procedures, and large-scale field trials to verify its safety and effectiveness from laboratory to commercial production, and then to widespread application in livestock farms.
Post time: Jun-18-2025